Patients from lower socioeconomic status (SES) backgrounds are more likely to undergo temporal artery biopsy (TAB) but are not at increased risk for biopsy-confirmed giant cell arteritis (GCA), ...

Dr. Kimberly Trotter distilled four high-impact disease clusters—gout, rheumatoid arthritis (RA), systemic lupus ...

The term giant cell arteritis (GCA) reflects the pathological feature seen on biopsy of involved vessels and is more inclusive of the variable presentations of this disease (Figure 1).

In one study of 161 patients with biopsy-proven GCA followed up for 11 years, the prevalence of visual ischemic complications was 26.1% and the prevalence of irreversible blindness, mainly due to ...

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a team at the Perelman School ...

Medicare may cover a biopsy if the procedure is medically necessary to diagnose a disease like cancer or tuberculosis. Most biopsies are outpatient procedures and are covered by Medicare Part B ...

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a Phase 3 clinical trial.

For example, just a couple of weeks ago, the third JAK to market, upadacitinib, recently got approval from the FDA for use in giant cell arteritis, and so in addition to the rheumatoid arthritis ...

VIDEO: Addressing inadequate response to JAK inhibitorsEditor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of ...